| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d249afbf826b5bdab9db767b9a2b08f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b81044c02bf6cfe16ca13488b339ed1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a2f7649b6c0b275a92ceb30a0b15fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85452fcc1ae9df25dde247ded897e155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3974560b90f4d5a2b745fb2d66466ac0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6951cc3d4a12e48bbc7096e358735ddf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B11-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L1-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2006-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_072fb2046fa80eb49d298c97dcfa143e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9c9026300b0d3a5e0cd7eb9a2bb92ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0f07d79ac0f8c03f4f73041845bb457
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5672275c978e6c4053136aed4fc33795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfde2a4ad680eaa02477e8e414e6841 |
| publicationDate |
2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8617604-B2 |
| titleOfInvention |
Pharmaceutical compositions with enhanced performance |
| abstract |
Pharmaceutical compositions of a low-solubility drug and lower alkanoate-, phthalate- and trimellitate esters of hydroxypropyl methyl cellulose and lower alkanoate- and succinate esters of cellulose and methyl cellulose are disclosed that provide enhanced concentrations of the drug in a use environment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973821-B2 |
| priorityDate |
2005-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |